Icelandair Group hf.
Icelandair Group has reached an agreement with Berjaya regarding sale of its remaining 25% share in Icelandair Hotels. The purchase price for the share is USD 3.4 million and will be payable at delivery of shares when conditions of the agreement have been fulfilled. The book value of the share is USD 13 thousand. Following the transaction, Icelandair Hotels will work on rebranding its hotels and eventually cease the usage of the Icelandair trademark.
Bogi Nils Bogason, President & CEO of Icelandair Group:
"The sale of the remaining shares in Icelandair Hotels is in line with the Company’s strategy of focusing on our core business, aviation and related services, going forward. I want to thank all the employees of Icelandair Hotels for their cooperation and their contribution in building up numerous high-quality hotels in Iceland, leading to a unique experience for our guests. I am confident that Iceland will continue to be an attractive tourist destination following the pandemic and that Icelandair Hotels will continue to play an important role in the further development of the Icelandic tourism market in the coming years. I want to thank Berjaya for a good cooperation during the past year and wish them and Icelandair Hotels all the best for the future."
Contact information:
Investors: Iris Hulda Thorisdottir, Director Investor Relations
E-mail: iris@icelandairgroup.is
Media: Asdis Petursdottir, Director Communications & CSR
E-mail: asdis@icelandair.is
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Global Electronics Association23.6.2025 06:01:00 CEST | Press release
Global Electronics Association Debuts; New Name Elevates IPC’s 70-Year Legacy as Voice of $6 Trillion Electronics Industry
Novo Nordisk A/S22.6.2025 21:35:25 CEST | Press release
Novo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data presented at the ISTH 2025 Congress
Bitget Limited22.6.2025 17:32:39 CEST | Press release
Bitget Partners with MotoGP for a High-Speed Collision of Tech and Speed
Novo Nordisk A/S22.6.2025 15:00:30 CEST | Press release
Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine
Ministry of Information & Broadcasting, Pakistan21.6.2025 15:18:54 CEST | Press release
Government of Pakistan Recommends President Donald J. Trump for 2026 Nobel Peace Prize
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom